Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

In vivo photoactivation without "light": use of Cherenkov radiation to overcome the penetration limit of light.

Ran C, Zhang Z, Hooker J, Moore A.

Mol Imaging Biol. 2012 Apr;14(2):156-62. doi: 10.1007/s11307-011-0489-z.

PMID:
21538154
2.

A selenium analogue of firefly D-luciferin with red-shifted bioluminescence emission.

Conley NR, Dragulescu-Andrasi A, Rao J, Moerner WE.

Angew Chem Int Ed Engl. 2012 Apr 2;51(14):3350-3. doi: 10.1002/anie.201105653. Epub 2012 Feb 17.

3.

Design and Synthesis of an Alkynyl Luciferin Analogue for Bioluminescence Imaging.

Steinhardt RC, O'Neill JM, Rathbun CM, McCutcheon DC, Paley MA, Prescher JA.

Chemistry. 2016 Mar 7;22(11):3671-5. doi: 10.1002/chem.201503944. Epub 2016 Jan 19.

4.

A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.

Godinat A, Park HM, Miller SC, Cheng K, Hanahan D, Sanman LE, Bogyo M, Yu A, Nikitin GF, Stahl A, Dubikovskaya EA.

ACS Chem Biol. 2013 May 17;8(5):987-99. doi: 10.1021/cb3007314. Epub 2013 Mar 29.

5.

Cage the firefly luciferin! - a strategy for developing bioluminescent probes.

Li J, Chen L, Du L, Li M.

Chem Soc Rev. 2013 Jan 21;42(2):662-76. doi: 10.1039/c2cs35249d. Review.

PMID:
23099531
6.

Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging.

Berger F, Paulmurugan R, Bhaumik S, Gambhir SS.

Eur J Nucl Med Mol Imaging. 2008 Dec;35(12):2275-85. doi: 10.1007/s00259-008-0870-6. Epub 2008 Jul 26.

7.

In vivo imaging of early stage apoptosis by measuring real-time caspase-3/7 activation.

Scabini M, Stellari F, Cappella P, Rizzitano S, Texido G, Pesenti E.

Apoptosis. 2011 Feb;16(2):198-207. doi: 10.1007/s10495-010-0553-1.

PMID:
21082356
8.

In vivo ¹⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation.

Boschi F, Calderan L, D'Ambrosio D, Marengo M, Fenzi A, Calandrino R, Sbarbati A, Spinelli AE.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):120-7. doi: 10.1007/s00259-010-1630-y. Epub 2010 Sep 30.

PMID:
20882278
9.

Firefly luciferase exhibits bimodal action depending on the luciferin chirality.

Nakamura M, Maki S, Amano Y, Ohkita Y, Niwa K, Hirano T, Ohmiya Y, Niwa H.

Biochem Biophys Res Commun. 2005 Jun 3;331(2):471-5.

PMID:
15850783
10.

Firefly luciferase can use L-luciferin to produce light.

Lembert N.

Biochem J. 1996 Jul 1;317 ( Pt 1):273-7.

11.

(18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.

Kang WJ, Song EH, Park JY, Park YJ, Cho A, Song HT.

Nucl Med Biol. 2015 Sep;42(9):728-33. doi: 10.1016/j.nucmedbio.2015.05.003. Epub 2015 May 27.

PMID:
26068116
12.

Luciferin derivatives for enhanced in vitro and in vivo bioluminescence assays.

Shinde R, Perkins J, Contag CH.

Biochemistry. 2006 Sep 19;45(37):11103-12.

PMID:
16964971
13.

3'-deoxy-3'-[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography.

Barthel H, Cleij MC, Collingridge DR, Hutchinson OC, Osman S, He Q, Luthra SK, Brady F, Price PM, Aboagye EO.

Cancer Res. 2003 Jul 1;63(13):3791-8.

15.

Dynamic 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography for Chemotherapy Response Monitoring of Breast Cancer Xenografts.

Kristian A, Holtedahl JE, Torheim T, Futsaether C, Hernes E, Engebraaten O, Mælandsmo GM, Malinen E.

Mol Imaging Biol. 2017 Apr;19(2):271-279. doi: 10.1007/s11307-016-0998-x.

PMID:
27541026
16.

Advances in the knowledge of light emission by firefly luciferin and oxyluciferin.

Vieira J, Pinto da Silva L, Esteves da Silva JC.

J Photochem Photobiol B. 2012 Dec 5;117:33-9. doi: 10.1016/j.jphotobiol.2012.08.017. Epub 2012 Sep 5. Review.

PMID:
23026386
17.

In vivo bioluminescence imaging.

Sato A, Klaunberg B, Tolwani R.

Comp Med. 2004 Dec;54(6):631-4. Review.

PMID:
15679260
18.

Multicolor Bioluminescence Obtained Using Firefly Luciferin.

Kiyama M, Saito R, Iwano S, Obata R, Niwa H, Maki SA.

Curr Top Med Chem. 2016;16(24):2648-55. Review.

PMID:
27072707
19.

Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.

Gross S, Abraham U, Prior JL, Herzog ED, Piwnica-Worms D.

Mol Imaging. 2007 Mar-Apr;6(2):121-30.

PMID:
17445506
20.

Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.

Shah C, Miller TW, Wyatt SK, McKinley ET, Olivares MG, Sanchez V, Nolting DD, Buck JR, Zhao P, Ansari MS, Baldwin RM, Gore JC, Schiff R, Arteaga CL, Manning HC.

Clin Cancer Res. 2009 Jul 15;15(14):4712-21. doi: 10.1158/1078-0432.CCR-08-2635. Epub 2009 Jul 7.

Supplemental Content

Support Center